HEALTHCARE RESOURCE UTILIZATION (HCRU) AND ASSOCIATED COSTS AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH ORAL AZACITIDINE AS MAINTENANCE AND THOSE ELIGIBLE BUT NOT TREATED USING A US CLAIMS DATABASE

被引：0

作者：

Borate, U. ^{[1
]}

Seiter, K. ^{[2
]}

Potluri, R. ^{[3
]}

Mazumder, D. ^{[3
]}

Heydendael, W. ^{[4
]}

Chevli, M. ^{[4
]}

Prebet, T. ^{[4
]}

Strocchia, M. ^{[4
]}

Vasconcelos, A. ^{[4
]}

Sieluk, J. ^{[4
]}

机构：

[1] Ohio State Univ, Columbus, OH USA

[2] New York Med Coll, Valhalla, NY USA

[3] Putnam Associates, New York, NY USA

[4] Bristol Myers Squibb, Princeton, NJ USA

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE86

引用

页码：S67 / S67

页数：1

共 50 条

[41] Treatment Patterns, Health Care Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data
Locklear, Julie C.
Alemayehu, Berhanu
Brody, Robert S.
Chavoshi, Soheil
Tunceli, Ozgur
Kern, David
Earley, Willie R.
[J]. CLINICAL THERAPEUTICS, 2013, 35 (12) : 1923 - 1932
[42] Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study
Corral, Mitra
DeYoung, Kathryn
Kong, Amanda M.
[J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
[43] Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study
Mitra Corral
Kathryn DeYoung
Amanda M. Kong
[J]. BMC Pulmonary Medicine, 20
[44] Comparing medication persistence, healthcare resource utilization and costs among newly diagnosed, newly treated patients using dabigatran vs warfarin.
Iorga, Serban R.
Bancroft, Tim
Lim, Jonathan
Wang, Cheng
Sander, Stephen D.
Swindle, Jason P.
[J]. PHARMACOTHERAPY, 2014, 34 (06): : E76 - E76
[45] Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: A real-world, retrospective, claims-based, comparative analysis
Smith B.D.
Beach C.L.
Mahmoud D.
Weber L.
Henk H.J.
[J]. Experimental Hematology & Oncology, 3 (1)
[46] HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS NEWLY TREATED FOR PULMONARY ARTERIAL HYPERTENSION IN A REAL-WORLD DATABASE REPRESENTING A LARGE US HEALTH PLAN
Hull, M.
Pruett, J.
Elliott, C.
Tsang, Y.
Drake, W.
[J]. VALUE IN HEALTH, 2019, 22 : S119 - S119
[47] Comparison of stroke- and bleed-related healthcare resource utilization (HCRU) among patients with non-valvular atrial fibrillation (NVAF), newly treated with oral anti-coagulants (OACs)
Gilligan, A.
Franchino-Elder, J.
Song, X.
Wang, C.
Henriques, C.
Sainski-Nguyen, A.
Wilson, K.
Smith, D. M.
Sander, S.
[J]. EUROPEAN HEART JOURNAL, 2017, 38 : 765 - 766
[48] Incremental Healthcare Resource Utilization and Costs Associated with Non-Optimal Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Tyrosine Kinase Inhibitors (TKI) in Early Lines of Therapy in the United States (US)
Kota, Vamsi K.
Wei, David
Yang, Daisy
Romdhani, Hela
Latremouille-Viau, Dominick
Guerin, Annie
Jadhav, Kejal
[J]. BLOOD, 2023, 142
[49] Healthcare resource utilization and costs among patients with rheumatoid arthritis on biologic therapies in Taiwan: A 1-year mirror-image study using a national claims database
Chen, Kuan-Chen
Wu, Chu-Hua
Tang, Chao-Hsiun
Huang, Kuo-Cherh
[J]. PLOS ONE, 2018, 13 (07):
[50] Erratum to: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis
B Douglas Smith
Charles L Beach
Dalia Mahmoud
Laura Weber
Henry J Henk
[J]. Experimental Hematology & Oncology, 3 (1)

← 1 2 3 4 5 →